slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
11,701-11,718 of 319,975
30
Team bio slide with contact details and office locations.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting 1 hit
31
Hospital Priorities 2022 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting 1 hit
01
Hospital Priorities 2023 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
02
The slide uses stacked bar charts to visualize the composition of the survey sample.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Situation & Context1 hit
03
NRDL=National Reimbursement Drug List; VBP=volume-based procurementHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Situation & Context1 hit
04
The table includes bilingual (English/Chinese) labels for spending categories.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
05
The chart highlights top priorities for hospitals regarding pharma support, with a specific callout regarding NRDL negotiation and VBP impact on drug costs.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
06
Data from L.E.K. 2023 APAC Hospital Priorities Survey (N=100).Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
07
The slide uses a consistent color-coded legend for years (2021, 2022, 2023) across three bar charts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
08
NRDL = National Reimbursement Drug List. Data from L.E.K. APAC Hospital Priorities Survey.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
09
The slide uses a stacked bar chart approach to visualize survey data regarding prescription outflow shifts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
10
The chart shows a clear shift toward higher acceptance of digital engagement in 2023 compared to 2022 across all hospital segments.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
11
The slide uses a bilingual (Chinese/English) format for labels.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
12
Includes a specific callout explaining a spike in privacy concerns due to China's PIPL law.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
13
The slide uses a stacked bar chart approach to visualize survey responses regarding financial health.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
14
The slide uses a numbered list to structure key strategic inquiries.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Aha Moment1 hit
15
Hospital Priorities 2023 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
16
The slide uses a bilingual (English/Chinese) table format to present survey results from 100 respondents.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit